183 related articles for article (PubMed ID: 24366374)
1. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
[TBL] [Abstract][Full Text] [Related]
2. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
[TBL] [Abstract][Full Text] [Related]
3. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
[TBL] [Abstract][Full Text] [Related]
5. Improved clearance of radioiodinated hypericin as a targeted anticancer agent by using a duodenal drainage catheter in rats.
Cona MM; Feng Y; Verbruggen A; Oyen R; Ni Y
Exp Biol Med (Maywood); 2013 Dec; 238(12):1437-49. PubMed ID: 24146264
[TBL] [Abstract][Full Text] [Related]
6. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.
Kong M; Zhang J; Jiang C; Jiang X; Li Y; Gao M; Yao N; Huang D; Wang X; Fang Z; Liu W; Sun Z; Ni Y
J Drug Target; 2013 Jul; 21(6):604-10. PubMed ID: 23627568
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.
Cona MM; Alpizar YA; Li J; Bauwens M; Feng Y; Sun Z; Zhang J; Chen F; Talavera K; de Witte P; Verbruggen A; Oyen R; Ni Y
Pharm Res; 2014 Feb; 31(2):278-90. PubMed ID: 23934256
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
Gao L; Zhang J; Ma T; Yao N; Gao M; Shan X; Ni Y; Shao H; Xu K
Oncotarget; 2016 Aug; 7(32):51450-51461. PubMed ID: 27285983
[TBL] [Abstract][Full Text] [Related]
12. Validation study of ¹³¹I-RRL: assessment of biodistribution, SPECT imaging and radiation dosimetry in mice.
Zhao Q; Yan P; Yin L; Li L; Chen XQ; Ma C; Wang RF
Mol Med Rep; 2013 Apr; 7(4):1355-60. PubMed ID: 23440460
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.
Liu X; Feng Y; Jiang C; Lou B; Li Y; Liu W; Yao N; Gao M; Ji Y; Wang Q; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Drug Target; 2015 Jun; 23(5):417-26. PubMed ID: 25655506
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and radiation dosimetry of [¹⁸F]-5-fluorouracil.
Hino-Shishikura A; Suzuki A; Minamimoto R; Shizukuishi K; Oka T; Tateishi U; Sugae S; Ichikawa Y; Horiuchi C; Inoue T
Appl Radiat Isot; 2013 May; 75():11-7. PubMed ID: 23416442
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Liu W; Zhang D; Feng Y; Li Y; Huang D; Jiang C; Gao M; Peng F; Wang X; Jing S; Jiang X; Ni Y; Zhang J
J Drug Target; 2015 May; 23(4):371-9. PubMed ID: 25572455
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs.
Abma E; Peremans K; De Vos F; Bosmans T; Kitshoff AM; Daminet S; Ni Y; Dockx R; de Rooster H
Vet Comp Oncol; 2018 Sep; 16(3):318-323. PubMed ID: 29314561
[TBL] [Abstract][Full Text] [Related]
17. Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.
Shao H; Zhang J; Sun Z; Chen F; Dai X; Li Y; Ni Y; Xu K
Oncotarget; 2015 Jun; 6(16):14247-59. PubMed ID: 26036625
[TBL] [Abstract][Full Text] [Related]
18. Radiation dosimetry estimates of [18F]-fluoroacetate based on biodistribution data of rats.
Zhang JP; Zhang YJ; Xu JY; Yang ZY
Appl Radiat Isot; 2012 Jan; 70(1):332-5. PubMed ID: 22019094
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hypericin: effect of aggregation on targeting biodistribution.
Liu X; Jiang C; Li Y; Liu W; Yao N; Gao M; Ji Y; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Pharm Sci; 2015 Jan; 104(1):215-22. PubMed ID: 25395358
[TBL] [Abstract][Full Text] [Related]
20. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]